Conversion from TAC-MMF to mTOR-TAC Immunosuppression in Kidney-Pancreas Transplantation Reduces the Incidence of BK Viremia.

被引：0
|
作者：
Knight, R. [1 ]
Patel, S. [1 ]
DeVos, J. [1 ]
Moore, L. [1 ]
Gaber, A. [1 ]
机构：
[1] Methodist Hosp, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：433 / 433
页数：1
相关论文
共 4 条
  • [1] Conversion From TAC-MMF To TAC-mTOR Immunosuppression After Kidney-Pancreas Transplantation
    Knight, R.
    DeVos, J.
    Patel, S.
    Gaber, A.
    TRANSPLANTATION, 2014, 98 : 856 - 857
  • [2] Conversion From TAC-MMF To TAC-mTOR Immunosuppression After Kidney-Pancreas Transplantation.
    Knight, R.
    DeVos, J.
    Patel, S.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 856 - 857
  • [3] Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
    Knight, Richard J.
    Graviss, Edward A.
    Nguyen, Duc T.
    Kuten, Samantha A.
    Patel, Samir J.
    Gaber, Lillian
    Gaber, A. Osama
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [4] EXPERIENCES WITH CONVERSION TO ONCE-DAILY ADVAGRAF AND SIROLIMUS COMBINATION FROM TAC-MMF IN STABLE KIDNEY RECIPIENTS
    Park, Kwan Tae
    Jung, C. W.
    Choi, Y. J.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 286 - 286
1